Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Other Non-Current Assets (2022 - 2025)

Historic Other Non-Current Assets for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $1.3 million.

  • Orchestra BioMed Holdings' Other Non-Current Assets fell 53.72% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 53.72%. This contributed to the annual value of $1.0 million for FY2024, which is 3263.98% up from last year.
  • Latest data reveals that Orchestra BioMed Holdings reported Other Non-Current Assets of $1.3 million as of Q3 2025, which was down 53.72% from $1.3 million recorded in Q2 2025.
  • Orchestra BioMed Holdings' Other Non-Current Assets' 5-year high stood at $4.7 million during Q4 2022, with a 5-year trough of $421000.0 in Q1 2023.
  • In the last 4 years, Orchestra BioMed Holdings' Other Non-Current Assets had a median value of $957000.0 in 2024 and averaged $1.2 million.
  • In the last 5 years, Orchestra BioMed Holdings' Other Non-Current Assets crashed by 8367.65% in 2023 and then surged by 11572.85% in 2024.
  • Over the past 4 years, Orchestra BioMed Holdings' Other Non-Current Assets (Quarter) stood at $4.7 million in 2022, then crashed by 83.68% to $769000.0 in 2023, then soared by 32.64% to $1.0 million in 2024, then increased by 27.06% to $1.3 million in 2025.
  • Its last three reported values are $1.3 million in Q3 2025, $1.3 million for Q2 2025, and $1.3 million during Q1 2025.